Newbury Pharmaceuticals AB (NEWBRY) — Defensive Interval Ratio
Newbury Pharmaceuticals AB (NEWBRY) has a Defensive Interval Ratio of 228 days as of February 2025. Defensive assets of Skr21.05 Million (cash Skr-, short-term investments Skr-, receivables Skr21.05 Million) cover 228 days of daily cash needs of Skr92.40K/day. See Newbury Pharmaceuticals AB (NEWBRY) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Newbury Pharmaceuticals AB Defensive Interval Ratio (2021–2024)
This chart shows how Newbury Pharmaceuticals AB's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of February 2025, the ratio stands at 228 days, meaning defensive assets of Skr21.05 Million can fund 228 days of operations without new revenue. See how leveraged is Newbury Pharmaceuticals AB's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Newbury Pharmaceuticals AB (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for Newbury Pharmaceuticals AB from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see NEWBRY market cap.
| Year | DIR (days) | Defensive Assets (SEK) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 293 days | Skr23.68 Million | Skr80.67K/day | Skr- | Skr- | ▲ +61 days |
| 2023 | 232 days | Skr7.48 Million | Skr32.24K/day | Skr- | Skr- | ▲ +150 days |
| 2022 | 82 days | Skr1.37 Million | Skr16.60K/day | Skr- | Skr- | ▼ -48 days |
| 2021 | 130 days | Skr1.54 Million | Skr11.89K/day | Skr- | Skr- | — |